scholarly journals Metabolic flexibility and insulin resistance

2008 ◽  
Vol 295 (5) ◽  
pp. E1009-E1017 ◽  
Author(s):  
Jose E. Galgani ◽  
Cedric Moro ◽  
Eric Ravussin

Metabolic flexibility is the capacity for the organism to adapt fuel oxidation to fuel availability. The inability to modify fuel oxidation in response to changes in nutrient availability has been implicated in the accumulation of intramyocellular lipid and insulin resistance. The metabolic flexibility assessed by the ability to switch from fat to carbohydrate oxidation is usually impaired during a hyperinsulinemic clamp in insulin-resistant subjects; however, this “metabolic inflexibility” is mostly the consequence of impaired cellular glucose uptake. Indeed, after controlling for insulin-stimulated glucose disposal rate (amount of glucose available for oxidation), metabolic flexibility is not altered in obesity regardless of the presence of type 2 diabetes. To understand how intramyocellular lipids accumulate and cause insulin resistance, the assessment of metabolic flexibility to high-fat diets is more relevant than metabolic flexibility during a hyperinsulinemic clamp. An impaired capacity to upregulate muscle lipid oxidation in the face of high lipid supply may lead to increased muscle fat accumulation and insulin resistance. Surprisingly, very few studies have investigated the response to high-fat diets. In this review, we discuss the role of glucose disposal rate, adipose tissue lipid storage, and mitochondrial function on metabolic flexibility. Additionally, we emphasize the bias of using the change in respiratory quotient to calculate metabolic flexibility and propose novel approaches to assess metabolic flexibility. On the basis of current evidence, one cannot conclude that impaired metabolic flexibility is responsible for the accumulation of intramyocellular lipid and insulin resistance. We propose to study metabolic flexibility in response to high-fat diets in individuals having contrasting degree of insulin sensitivity and/or mitochondrial characteristics.

2008 ◽  
Vol 19 (8) ◽  
pp. 505-513 ◽  
Author(s):  
Anne M. Flanagan ◽  
Jackie L. Brown ◽  
Consuelo A. Santiago ◽  
Pauline Y. Aad ◽  
Leon J. Spicer ◽  
...  

2019 ◽  
Vol 3 (Supplement_1) ◽  
Author(s):  
Sarah Wong ◽  
Rafael de Cabo ◽  
Michel Bernier ◽  
Alberto Diaz-Ruiz ◽  
Tyler Rhinesmith ◽  
...  

Abstract Objectives 4:10 periodic fasting schedule is proposed to improve biomarkers of healthspan through metabolic flexibility in mice on both standard and high fat diets. Methods Our study adopted the 4:10 fasting schedule using the fasting-mimicking diet (FMD) as our model. FMD is a plant-based, low-protein, and low-sugar diet regime implemented for four days every two-week cycle. Its regenerative effect is observed in the refeeding phase following starvation, allowing for the breakdown of cells via increased autophagy. In comparison to stricter fasting regimes such as intermittent fasting, chronic caloric restriction, and periodic fasting, FMD is well-tolerated in the clinical setting. 74 12-month old C57BL/6 mice were randomized into two diet groups: standard diet or high-fat diet. For 4 days out of every fourteen days, the mice were severely caloric restricted and refed with ad-libitum of either standard or high fat diets for the remaining 10 days, matching the controls who were fixed on the ad-libitum diet. The 4:10 fasting schedule was repeated 11 times before the mice were sacrificed. To measure metabolic flexibility, metabolic cages, ELISA, and glucose meters were used. Results Body weight and composition, metabolic flexibility, and insulin sensitivity indicate differences between fasting on diet composition. Not only did those on the fasting high-fat diet (FHFD) remain overweight, identical to their HFD controls, insulin sensitivity was also attenuated in FHFD groups. Fasting standard diet (FSD) had a reduction of 5% in body weight and 15% in body fat. Carbohydrate and lipid metabolism differences indicated by the respiratory exchange ratio as well as motor function performance differences further support the positive impact of fasting on SD groups, not HFD groups. Characteristic of positive healthspan biomarkers, reduced leptin and improved insulin sensitivity was observed with FSD, not FHFD. Conclusions We found that while the FMD schedule improved healthspan as indicated by biomarkers of healthy aging for mice on the standard diet, it could not counteract the negative health effects of the obesogenic diet. These results demonstrate the importance of not only time of feeding but also diet composition in respect to healthspan. Funding Sources National Institute on Aging (NIA) – National Institutes of Health (NIH).


2007 ◽  
Vol 86 (5) ◽  
pp. 1316-1322 ◽  
Author(s):  
Marie-Pierre St-Onge ◽  
Bradley R Newcomer ◽  
Steven Buchthal ◽  
Inmaculada Aban ◽  
David B Allison ◽  
...  

PLoS ONE ◽  
2015 ◽  
Vol 10 (6) ◽  
pp. e0128515 ◽  
Author(s):  
Loes P. M. Duivenvoorde ◽  
Evert M. van Schothorst ◽  
Hans M. Swarts ◽  
Ondrej Kuda ◽  
Esther Steenbergh ◽  
...  

2011 ◽  
Vol 22 (4) ◽  
pp. 366-371 ◽  
Author(s):  
Johan De Vogel-van den Bosch ◽  
Sjoerd A.A. van den Berg ◽  
Silvia Bijland ◽  
Peter J. Voshol ◽  
Louis M. Havekes ◽  
...  

2009 ◽  
Vol 297 (5) ◽  
pp. R1302-R1311 ◽  
Author(s):  
Stéphane Boghossian ◽  
Karalee Lemmon ◽  
MieJung Park ◽  
David A. York

Intracerebroventricular insulin decreases food intake (FI) . The central bed nucleus of the amygdala (CeA), as other regions of the brain regulating feeding behavior, expresses insulin receptors. Our objectives were to show an insulin anorectic response in the amygdala, study the effect of high-fat diets on this response, and map the neural network activated by CeA insulin using c-Fos immunohistochemistry. Sprague-Dawley (SD) rats fitted with unilateral CeA cannulas were adapted to a low-fat (LFD) diet before they were fed a high-fat diet (HFD). Their feeding response to CeA saline or insulin (8 mU) was tested after 24 h, 72 h, or 7 days of being on a HFD. In a second experiment, SD rats were fed the HFD for 3, 7, or 49 days and were then refed with the LFD. They were tested for their insulin response before and after an HFD and every 3 days for the following weeks. Insulin tolerance tests were performed in a parallel group of rats. The CeA insulin stimulation c-Fos expression was studied to identify the distribution of activated neuronal populations. Feeding an HFD for 72 h or more induced a CeA, but not peripheral, insulin resistance, which was slowly reversed by LFD refeeding. The duration of HFD feeding determined the time frame for reversal of the insulin resistance. CeA insulin increased c-Fos in multiple brain regions, including the arcuate nucleus/paraventricular nucleus region of the hypothalamus. We conclude that the amygdala may be an important site for insulin regulation of food intake and may have a significant role in determining susceptibility to HFD-induced obesity.


2009 ◽  
Vol 25 (2) ◽  
pp. 185-194 ◽  
Author(s):  
Silvia Wein ◽  
Siegfried Wolffram ◽  
Jürgen Schrezenmeir ◽  
Daniela Gašperiková ◽  
Iwar Klimeš ◽  
...  

Antioxidants ◽  
2021 ◽  
Vol 10 (8) ◽  
pp. 1251
Author(s):  
Yuqing Tan ◽  
Christina C. Tam ◽  
Matt Rolston ◽  
Priscila Alves ◽  
Ling Chen ◽  
...  

Quercetin is a flavonoid that has been shown to have health-promoting capacities due to its potent antioxidant activity. However, the effect of chronic intake of quercetin on the gut microbiome and diabetes-related biomarkers remains unclear. Male C57BL/6J mice were fed HF or HF supplemented with 0.05% quercetin (HFQ) for 6 weeks. Diabetes-related biomarkers in blood were determined in mice fed high-fat (HF) diets supplemented with quercetin. Mice fed the HFQ diet gained less body, liver, and adipose weight, while liver lipid and blood glucose levels were also lowered. Diabetes-related plasma biomarkers insulin, leptin, resistin, and glucagon were significantly reduced by quercetin supplementation. In feces, quercetin supplementation significantly increased the relative abundance of Akkermansia and decreased the Firmicutes/Bacteroidetes ratio. The expression of genes Srebf1, Ppara, Cyp51, Scd1, and Fasn was downregulated by quercetin supplementation. These results indicated that diabetes biomarkers are associated with early metabolic changes accompanying obesity, and quercetin may ameliorate insulin resistance.


2008 ◽  
Vol 105 (22) ◽  
pp. 7815-7820 ◽  
Author(s):  
C. R. Hancock ◽  
D.-H. Han ◽  
M. Chen ◽  
S. Terada ◽  
T. Yasuda ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document